de Martel C, et al. - A worldwide incidence analysis was conducted to improve estimates of the global and regional burden of infection-attributable cancers to inform research priorities and facilitate prevention efforts. The GLOBOCAN 2018 database of cancer incidence and mortality rates was applied and attributable fractions and global incidence were evaluated for specific anatomical cancer sites, subsites, or histological subtypes known to be correlated with ten infectious pathogens classified as human carcinogens. Absolute numbers and age-standardized incidence rates (ASIR) of infection-attributable cancers at the country level were estimated. In addition to the absolute number of cases infection-attributable cancer incidence, provides for refined geographic investigations and identification of populations with a high infection-associated cancer burden. The data showed that there is a crucial demand for resources directed towards cancer prevention programmes that target infection, when cancer prevention is largely considered in a non-communicable disease context, especially in high-risk populations.